Suchergebnisse - "Nakagami, Hironori"

PubPharm (456)

1

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies

enthalten in: bioRxiv.org | 2023

von Lu, X. | Hayashi, H. | Ishikawa, E. | +4

2

Conjugate vaccine targeting a disease-causing biological protein

enthalten in: Europäisches Patentamt | 2023

von NAKAGAMI HIRONORI | MORISHITA RYUICHI | TENMA AKIKO

3

Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2

enthalten in: The Tohoku journal of experimental medicine | 2023

von Lee, E. | Suzuki, Y. | Tomioka, H. | +2

4

Wnt SIGNALING PATHWAY INHIBITOR

enthalten in: Europäisches Patentamt | 2023

von SHIMAMURA MUNEHISA | NAKAGAMI HIRONORI | MORISHITA RYUICHI

5

Wnt SIGNALING PATHWAY INHIBITOR

enthalten in: Europäisches Patentamt | 2023

von SHIMAMURA MUNEHISA | NAKAGAMI HIRONORI | MORISHITA RYUICHI

6

Preventive or therapeutic method for inflammatory skin disease

enthalten in: Europäisches Patentamt | 2023

von SHIMAMURA MUNEHISA | NAKAGAMI HIRONORI | IKEDA YUKA | +2

7

Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine

enthalten in: NPJ vaccines | 2023

von Fukami, H. | Morinaga, J. | Nakagami, H. | +12

8

IMPROVED DNA VACCINE FOR SARS-COV-2

enthalten in: Europäisches Patentamt | 2023

von NAKAGAMI HIRONORI | MORISHITA RYUICHI | HAYASHI HIROKI | +6

9

IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN

enthalten in: Europäisches Patentamt | 2023

von NAKAGAMI HIRONORI | MORISHITA RYUICHI | TAKEDA SHUKO | +1

10

IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN

enthalten in: Europäisches Patentamt | 2023

von NAKAGAMI HIRONORI | MORISHITA RYUICHI | TAKEDA SHUKO | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[46]